1,425
Views
3
CrossRef citations to date
0
Altmetric
Coronaviruses

Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain)

, , , , , , , , , , , , & ORCID Icon show all
Article: 2202281 | Received 12 Dec 2022, Accepted 07 Apr 2023, Published online: 01 May 2023

References

  • Sievers C, Zacher B, Ullrich A, et al. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022. Eurosurveillance. 2022: 27.
  • Pulliam JRC, van Schalkwyk C, Govender N, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022;376:eabn4947.
  • Ruff J, Zhang Y, Kappel M, et al. Rapid increase in suspected SARS-CoV-2 reinfections, Clark County, Nevada, USA, December 2021. Emerg Infect Dis J. 2022: 28.
  • Lewnard JA, Hong V, Tartof SY. Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome. medRxiv. 2022;2022.07.31.22278258. Available from: http://medrxiv.org/content/early/2022/08/02/2022.07.31.22278258.abstract.
  • Ciuffreda L, Alcoba-Florez J, Lorenzo-Salazar JM, et al. Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021. J Infect. 2022;85:90–122.
  • Ciuffreda L, González-Montelongo R, Alcoba-Florez J, et al. Tracing the trajectories of SARS-CoV-2 variants of concern between December 2020 and September 2021 in the Canary Islands (Spain). Front Cell Infect Microbiol. 2022;12:919346.
  • Alcoba-Florez J, Gil-Campesino H, Artola D-M de, et al. Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection. Int J Infect Dis. 2020;99:190–192.
  • Patel H, Varona S, Monzón S, et al. nf-core/viralrecon: nf-core/viralrecon v2.5. 2022.
  • O’Toole Á, Scher E, Underwood A, et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021;7:veab064.
  • Aksamentov I, Roemer C, Hodcroft EB, et al. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6:3773.
  • World Health Organization. Public health surveillance for COVID-19: interim guidance. Geneva, Switzerland; 2022. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-SurveillanceGuidance-2022.2.
  • R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020; Available from: https://www.r-project.org/.
  • Cao Y, Yisimayi A, Jian F, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608:593–602.
  • Hachmann NP, Miller J, Collier AY, et al. Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med. 2022;387:86–88.
  • Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185:2422–2433.e13.
  • Wang Q, Guo Y, Iketani S, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022;608:603–608.
  • Wolter N, Jassat W, Walaza S, et al. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat Commun. 2022;13:5860.
  • Sentis C, Billaud G, Bal A, et al. SARS-CoV-2 omicron variant, lineage BA.1, is associated with lower viral load in nasopharyngeal samples compared to delta variant. Viruses. 2022: 14.
  • Takatsuki Y, Takahashi Y, Nakajima J, et al. Viral load of SARS-CoV-2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5. Immunity, Inflamm Dis. 2023;11:e783.
  • Rees EM, Nightingale ES, Jafari Y, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18:270.